icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Veropharm posts FY 2010 Net Profit of 1.207 billion Roubles

Veropharm posts FY 2010 Net Profit of 1.207 billion Roubles
Russian pharmaceutical maker, Veropharm, has posted a FY 2010 Net profit of 1.207 billion Roubles under IFRS.

­The bottom line is up 9% on the FY 2009 1.107 billion rouble Net Profit, with EBITDA up 15% year on year to 1.6 billion roubles, as Revenues rose 23% to 5.4 billion roubles from 4.4 billion roubles a year earlier.

The company says the figures reflect a growing share of OTC drugs, which reached 75.6% of total sales. In 2010 exports accounted for 3.7% of the Company’s total finished goods sales compared to 2.5% in 2009. The company informed that as of the end of 2010 company debt decreased by 53% to 464.8 million roubles.